본문으로 바로가기
현재 위치:
진료안내
진료과
의료진 소개
카카오 프린트

의료진 소개

김아람 의사
김아람 [ 비뇨의학과, 로봇수술센터, 신경인성방광클리닉 ]

배뇨장애, 방광암, 전립선질환, 방광통증증후군, 소아비뇨기질환, 요실금, 로봇수술, 신경인성방광클리닉

고맙습니다 예약문의
1588-1533
외래진료 외래진료 특수클리닉 특수클리닉
진료일정 05
진료일정(날짜, 오전, 오후)
날짜
오전
오후

논문

논문
  • Kim AR. Hybrid Bladder Phantom to Validate Next-Generation Optical Wearables for Neurogenic Bladder Volume Monitoring.  International Neurourology Journal. 2023 Nov;27(Suppl 2):S82-90. 
  • Kim AR. Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers.  International Journal of Stem Cells. 2023 May;16(2):215-33. 
  • Kim AR. Advanced 3D Dynamic Culture System with Transforming Growth Factor-β3 Enhances Production of Potent Extracellular Vesicles with Modified Protein Cargoes via Upregulation of TGF-β Signaling.  Journal of Advanced Research. 2023 May;47:57-74. 
  • Kim AR. Advancing Patient Care: Innovative Use of Near-Infrared Spectroscopy for Monitoring Urine Volume in Neurogenic Bladder.  International Neurourology Journal. 2023 May;27(Suppl 1):S27-33. 
  • Kim AR, Shin HJ. Bioactive peptides for boosting stem cell culture platform: Methods and applications.  Biomedicine & Pharmacotherapy. 2023 Apr;160:114376. 
  • Kim AR. The Innovative Approach in Functional Bladder Disorders: The Communication Between Bladder and Brain-Gut Axis.  International Neurourology Journal. 2023 Mar;27(1):15-22. 
  • Park KS, Shin HJ, Kim AR. The Orphan GPR50 Receptor Regulates the Aggressiveness of Breast Cancer Stem-like Cells via Targeting the NF-kB Signaling Pathway.  International Journal of Molecular Sciences. 2023 Feb;24(3):2804. 
  • Park KS, Kim AR. Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer.  Journal of Translational Medicine. 2023 Feb 18;21:129. 
  • Kim AR, Park KS, Shin HJ. TTYH3 Modulates Bladder Cancer Proliferation and Metastasis via FGFR1/H-Ras/A-Raf/MEK/ERK Pathway.  International Journal of Molecular Sciences. 2022 Sep;23(18):10496. 
  • Kim AR. Superior therapeutic activity of TGF-β-induced extracellular vesicles against interstitial cystitis.  Journal of Controlled Release. 2022 Aug;348:924-37. 
  • Song K, Dayem AA, Lee S, Choi Y, Lim KM, Kim S, An J, Shin Y, Park H, Jeon TI, Jang SB, Bong H, Lee JI, Kang GH, Kim S, Kim A, Cho SG. Superior therapeutic activity of TGF-β-induced extracellular vesicles against interstitial cystitis.  J Control Release. 2022 Jun 29;348:924-937. doi: 10.1016/j.jconrel.2022.06.045. Online ahead of print. 
  • Kim AR. New therapeutic approach with extracellular vesicles from stem cells for interstitial cystitis/bladder pain syndrome.  BMB Reports. 2022 May;55(5):205-12. 
  • Kim AR, Kim HG. RNA-based biomarkers for the diagnosis, prognosis, and therapeutic response monitoring of prostate cancer.  Urologic Oncology. 2022 Mar;40(3):105.e1-e10. 
  • Ahn JH, Kang CK, Kim EM, Kim AR, Kim A. Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers.  Life (Basel). 2022 Mar 9;12(3):395. doi: 10.3390/life12030395. PMID: 35330146. 
  • Bae J, Yang SH, Kim A, Kim HG. RNA-based biomarkers for the diagnosis, prognosis, and therapeutic response monitoring of prostate cancer.  Urol Oncol. 2022 Mar;40(3):105.e1-105.e10. doi: 10.1016/j.urolonc.2021.11.012. Epub 2021 Dec 21. PMID: 34952790 . 
  • Kim AR, Choi WS, Park HG, Paick SH, Ahn JH, Kim HG. What Is the Cause of Recurrent Urinary Tract Infection? Contemporary Microscopic Concepts of Pathophysiology.  International Neurourology Journal. 2021 Sep;25(3):192-201. 
  • Kim AR, Choi WS, Paick SH, Kim HG, Ahn JH. Comparison of long-term effect and complications between holmium laser enucleation and transurethral resection of prostate: Nations-wide health insurance study.  Urology. 2021 Aug;154:300-7. 
  • Shin HJ, Kim AR, Park HK, Paick SH, Kim HG. Improvement in Near Vision following Silodosin Treatment in Patients With Lower Urinary Tract Symptoms.  International Neurourology Journal. 2021 Jun;25(2):164-71. 
  • Kim AR, Choi WS, Park HK, Kim HG, Ahn JH, Paick S. Clinical significance of 5-α reductase inhibitor and androgen deprivation therapy in bladder cancer incidence, recurrence, and survival: a meta-analysis and systemic review.  Aging Male. 2020 Dec;23(5):971-8. 
  • Kim AR, Park KS. Expression of ATP/GTP Binding Protein 1 Has Prognostic Value for the Clinical Outcomes in Non-Small Cell Lung Carcinoma.  Journal of Personalized Medicine. 2020 Dec 2;10(4):263. 
  • Kim AR. Commentary on “New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave”.  International Neurourology Journal. 2020 Dec;24(4):387-8. 
  • Kim AR, Kim HG. Current Overview of Surgical Options for Female Stress Urinary Incontinence.  International Neurourology Journal. 2020 Sep;24(3):222-30. 
  • Kim HG, Kim AR. Bioinformatics Approach for Identifying Novel Biomarkers and Their Signaling Pathways Involved in Interstitial Cystitis/Bladder Pain Syndrome with Hunner Lesion.  Journal of Clinical Medicine. 2020 Jun;9(6):1935. 
  • Kim AR. Improved Isolation and Culture of Urine-Derived Stem Cells (USCs) and Enhanced Production of Immune Cells from the USC-Derived Induced Pluripotent Stem Cells.  Journal of Clinical Medicine. 2020 Mar;9(3):827. 
  • Kim AR. Application of Adult and Pluripotent Stem Cells in Interstitial Cystitis/Bladder Pain Syndrome Therapy: Methods and Perspectives.  Journal of Clinical Medicine. 2020 Mar;9(3):766. 
  • Kim A, Kim MS, Park YJ, Choi WS, Park HK, Paick SH, Kim HG. Retropubic versus Transobturator Mid Urethral Slings in Patients at High Risk for Recurrent Stress Incontinence: A Systematic Review and Meta-Analysis.  J Urol. 2019 Jul;202(1):132-142. 
  • Kim A, Shin JH, Choo MS. Is It Possible to Prevent Symptom Recurrence After Transurethral Resection for Hunner Lesion?.  Int Neurourol J. 2018 Jun;22(2):145-148. doi: 10.5213/inj.1836082.041. Epub 2018 Jun 30. 
  • Kim A, Park YJ, Heo KO, Choi WS, Park HK, Paick SH, Choo MS, Kim HG. Novel symptom questionnaire for the differential diagnosis of detrusor underactivity and bladder outlet obstruction in men.  Aging Male.  2018 Jul 9:1-6. doi: 10.1080/13685538.2018.1481941. 
  • Kim A, Kim MS, Park YJ, Choi WS, Park HK, Paick SH, Choo MS, Kim HG. An Updated Systematic Review and Meta-analysis: Clinical Outcome of Single-Incision Slings Excluding TVT-Secur versus Standard Slings in Surgical Management of Stress Incontinence.  BJU Int. 2018 Jun 21. doi: 10.1111/bju.14447. 
  • Kim A, Kim M, Jeong SU, Song C, Cho YM, Ro JY, Ahn H. Level of invasion into fibromuscular band is an independent factor for positive surgical margin and biochemical recurrence in men with organ confined prostate cancer.  BMC Urol. 2018 Feb 2;18(1):7. doi: 10.1186/s12894-018-0321-z. 
  • Kim A, Nam W, Song SH, Jeong IG, Hong B. Use of the Ileum for Ureteral Stricture and Obstruction in Bilateral, Unilateral, and Single-kidney Cases.  Urology. 2018 Jan;111:203-207. doi: 10.1016/j.urology.2017.08.008. Epub 2017 Aug 14. 
  • Kim A, Hoe KO, Shin JH, Choo MS. Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment.  Investig Clin Urol. 2017 Sep;58(5):353-358. doi: 10.4111/icu.2017.58.5.353. Epub 2017 Aug 3. 
  • Kim A, Yu HY, Lim J, Ryu CM, Kim YH, Heo J, Han JY, Lee S, Bae YS, Kim JY, Bae DJ, Kim SY, Noh BJ, Hong KS, Han JY, Lee SW, Song M, Chung HM, Kim JK, Shin DM, Choo MS. Improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome.  Sci Rep. 2017 Aug 21;7(1):8872. doi: 10.1038/s41598-017-09330-x. 
  • Kim A, Han JY, Ryu CM, Yu HY, Lee S, Kim Y, Jeong SU, Cho YM, Shin DM, Choo MS. Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.  Histopathology. 2017 Sep;71(3):415-424. doi: 10.1111/his.13235. Epub 2017 Jun 16. 
  • Kim A, Lee KS, Kim TB, Kim HJ, Yoo ES, Yun JH, Kim DY, Jung SG, Lee JT, Kim JM, Oh CK, Shin JH, Jeon SH, Lee SH, Han CH, Lee DH, Cho HJ, Choo MS. Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment.  Investig Clin Urol. 2017 Jan;58(1):42-47. doi: 10.4111/icu.2017.58.1.42. Epub 2017 Jan 5. 
  • Kim A, Lee KS, Jung R, Na S, Kim JC, Kim HG, Choo MS. Health Related Quality of Life in Patients with Side-Effects after Antimuscarinic Treatment for Overactive Bladder.  Low Urin Tract Symptoms. 2017 Sep;9(3):171-175. doi: 10.1111/luts.12132. Epub 2016 Jun 12. 
  • Kim A, Yu HY, Heo J, Song M, Shin JH, Lim J, Yoon SJ, Kim Y, Lee S, Kim SW, Oh W, Choi SJ, Shin DM, Choo MS. Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder.  Sci Rep. 2016 Aug 2;6:30881. doi: 10.1038/srep30881. 
  • Kim A, Shin DM, Choo MS. Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.  Curr Urol Rep. 2016 Jan;17(1):1. doi: 10.1007/s11934-015-0563-1. Review. 
  • Kim A, Kwon T, You D, Jeong IG, Go H, Cho YM, Hong JH, Ahn H, Kim CS. Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.  J Korean Med Sci. 2015 Apr;30(4):385-9. doi: 10.3346/jkms.2015.30.4.385. Epub 2015 Mar 19. 
  • Kim A, Lim B, Song M, Choo MS. Pretreatment features to influence effectiveness of intravesical hyaluronic Acid instillation in refractory interstitial cystitis/painful bladder syndrome.  Int Neurourol J. 2014 Sep;18(3):163-7. doi: 10.5213/inj.2014.18.3.163. Epub 2014 Sep 24.